A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321

Summary

The purpose of this study is to evaluate the long-term safety of A-623 in subjects with SLE.

Timeline

Start

2011-04

Primary completion

2013-07

Completion

2013-10

Drugs

Indications